RHÖN-KLINIKUM AG | 10/25/2018

RHÖN-KLINIKUM AG issued a Schuldschein loan of EUR 100 million

RHÖN-KLINIKUM AG has successfully placed a Schuldschein loan of EUR 100 million on the market. The transaction was oversubscribed several times due to high demand from various investors, including savings banks, volksbanks and commercial banks. The majority of the volume was placed in the long maturities. Long-term financing and planning security is provided by the combination of exclusively fixed-interest tranches with different maturities.

RHÖN-KLINIKUM AG took advantage of the favourable interest rate environment to secure attractive long-term conditions on the Schuldschein loan market. The exclusively fixed tranches were successfully offered on the market with maturities of 5, 7 and 10 years. The funds raised are used for general corporate financing.

"The high demand for the Schuldschein loan, especially for its long maturities, testifies to investors' confidence in our company. With the RHÖN Campus concept and our digitalization strategy, we are assuming a pioneering role in the hospital landscape and offering a viable solution model for healthcare services of tomorrow. The Schuldschein loan is a logical addition to the syndicated credit line we already concluded last year and is part of our long-term financing strategy," says Stephan Holzinger, CEO of RHÖN-KLINIKUM AG.

"With an average duration of 8.7 years, we were able to achieve an exceptionally long-term result despite the current situation on the capital market. With the financing mix from our syndicated credit facility and the Schuldschein loan, we are in a position to sustainably finance the investment measures in our clinical locations and our campus strategy," adds Igor Levit, Head of Accounting, Taxes, Controlling and Financing at RHÖN-KLINIKUM AG.

RHÖN-KLINIKUM AG reduced all financial liabilities in 2014 following the strategic realignment. The company is characterised by a high and healthy equity base, sustainable internal financing power and a strong liquidity situation in the three-digit million euro range. For the first time since 2014, the clinic group is once again involving the capital market in corporate financing. 2 / 2

"We would like to thank our investors for the trust they have placed in us. We are pleased that we were able to successfully assert ourselves on the capital market in the face of intense competition from national and international companies and to market the transaction at the lower end of the price range. The attractive conditions provided us with the most favourable refinancing in the history of the company. The Schuldschein loan also gives us a high degree of flexibility," says Julian Schmitt, Head of Investor Relations and Treasury at RHÖN-KLINIKUM AG.

The placement of the Schuldschein loan was supported by Bayerische Landesbank and DZ BANK as joint arrangers. The company was advised on the transaction by Aybrook Financial Partners and the law firm Gütt Olk Feldhaus.


RHÖN‐KLINIKUM AG is one of the largest healthcare providers in Germany. The hospital group offers excellent medical care with a direct link to universities and research institutes. More than 830,000 patients are treated every year at the five group hospitals located in Bad Berka, Bad Neustadt, Frankfurt (Oder), Giessen and Marburg where approx. 16,700 employees work. With the RHÖN campus concept the Company is currently implementing a new and forward-looking project which raises fully comprehensive healthcare in rural areas to a new level of excellence and is geared to the growing needs of patients.

Contact Persons:


Elke Pfeifer Head of Corporate Communication & Marketing

Telephone: +49 9771 65-1327 | E-Mail:


Julian Schmitt Head of Investor Relations and Treasury

Telephone: +49 9771 65-1536 | E-Mail: